🌐 EN ▾
  • EN - English
  • FR - French
  • DE - German
  • JP - Japanese
  • KR - Korean
Wellness Background

LIPOSOMAL NMN

Cellular Energy & Longevity, Delivered with Liposomal Precision

NMN - The Precursor to NAD+

NMN (Nicotinamide Mononucleotide) is a natural molecule and direct precursor to NAD+, a key coenzyme for energy production and cellular repair. Supplementing NMN helps boost NAD+ levels, supporting healthy aging, metabolism, brain function and energy

Challenge related to bioavailability

Despite its potential, NMN faces stability issues and poor bioavailability, leading to reduced absorption and limited effectiveness in sustaining NAD+ levels when delivered through conventional supplements.

The Liposomal Advantage

Liposomal NMN employs DFS Technology™ (Dietary Fiber Stabilized), a patent-filed delivery system that protects NMN, enhances stability, and promotes targeted delivery to your cells, ensuring maximum effectiveness for vitality, cognitive function and overall wellness

Backed by Science, Proven in Research

Cellular Uptake (Caco-2 studies):

Liposomal NMN demonstrated 2x higher intestinal permeability compared to Conventional NMN.

Analytical Validation:

Characterized through TEM, Zeta Potential and PDI confirming uniformity and stability of Liposomal NMN.

Grade/Specification Available Form
Liposomal NMN 50% Powder

Core benefits of Liposomal NMN

NAD+ Icon

Supports
NAD+ Levels

Healthy Aging Icon

Enhances
Healthy Aging

Cognitive Icon

Supports
Cognitive Function

Metabolic Icon

Enhances
Metabolic Health

Why Liposomal NMN is Superior?

Feature
Liposomal NMN
Conventional NMN
Absorption Technology
DFS Technology™ – advanced liposomal delivery
Basic form – lower bioavailability
Stability & Efficacy
Protected from degradation, stable & potent
Unstable, prone to digestive breakdown
Cellular Uptake
2× higher (Caco-2 proven
Low, limited by hydrophobicity
Analytical Validation
TEM, Zeta, PDI advanced validation
No advanced validation
Tolerance
Gentle and effective delivery
May require higher doses, limited efficacy

Backed by External Peer-Reviewed Research

ANNALS OF CLINICAL AND MEDICAL CASE REPORTS

STUDY YEAR | 2025 | Satoshi Kawakami et al.

Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide...

READ THE STUDY

ELSIVIER | Mechanisms of Ageing and Development

STUDY YEAR | 2024 | Ajla Hodzic Kuerec et al.

Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD)...

READ THE STUDY

ELSEVIER | Clinical Nutrition ESPEN

STUDY YEAR | 2023 | Takuya Yamane et al.

Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects...

READ THE STUDY

SPRINGER NATURE | GeroScience

STUDY YEAR| 2023 | Lin Yi et al.

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a...

READ THE STUDY

NATURE | Scientific Reports

STUDY YEAR | 2023 | Takeshi Katayoshi et al.

Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide...

READ THE STUDY

SPRINGER NATURE | Molecular Biology Reports

STUDY YEAR | 2022 | Mounica Soma et al.

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic...

READ THE STUDY

Š 2026 LipsoBioŽ All Rights Reserved.

Disclaimer -

Please note that this website and the information provided are not intended for end consumers of finished food, beverage, dietary supplement, or cosmetic products, as the content here does not pertain to consumer-ready finished products. The statements related to ingredients on the website has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. By continuing to browse, you acknowledge and accept the terms outlined above.

top